Istari Oncology Announces FDA Grants Fast-Track Status to PVSRIPO for the Treatment of Advanced Melanoma | Companies

News Godzilla
Copyright 2021 novcog.com news network We rock so you don''t have to.


Istari Oncology Announces FDA Grants Fast-Track Status to PVSRIPO for the Treatment of Advanced Melanoma | Companies Istari Oncology Announces FDA Grants Fast-Track Status to PVSRIPO for the Treatment of Advanced Melanoma | Companies

DURHAM, NC – (BUSINESS WIRE) – Nov. June 2021– Istari Oncology, Inc., a clinical-stage biotechnology company focused on novel immunotherapy platforms for the treatment of solid tumors, announced today that the US Food and Drug Administration (FDA) has granted PVSRIPO fast-track status for improved survival Patients with advanced melanoma with disease progression after anti-PD-1 / […]The post..
previous post